The ability of natural and synthetic glucocorticoids to elicit numerous and diverse physiological responses is remarkable. How the product of a single gene can participate in such a myriad of cell and tissue specific pathways has remained largely unknown. The last several years have seen increased description of GR protein isoforms. Here we review the current state of knowledge regarding naturally occurring GR isoforms and discuss how this array of receptor species generates the diversity associated with the glucocorticoid response. We propose that the multiplicity of receptor forms have unique tissue-specific actions on the downstream biology providing a mechanism to create GR signaling networks.
INTRODUCTION
Glucocorticoids are a vital class of steroid hormones that mediate profound and diverse physiological effects in vertebrates from fish to man. Produced and secreted by the adrenal cortex, levels of circulating glucocorticoids are regulated by adrenocorticotropin (ACTH) largely under the control of the hypothalmic-pituitaryadrenal axis (HPA).
Although named for their role in glucose homeostasis, glucocorticoids are also eminently important throughout physiology, with regulatory roles in development, metabolism, neurobiology, programmed cell death and many other functions.
In addition to these far-reaching physiological roles, corticosteroids are among the most widely prescribed class of drugs in the world. The pharmacological benefits of glucocorticoids are primarily anti-inflammatory and immunosuppressive.
They also find widespread use in chemotherapeutic regimes in patients with leukemias, lymphomas and other cancers due to their critical role in the induction of apoptosis.
The physiological response and sensitivity to glucocorticoids varies among species, individuals, tissues, cell types, and even during the cell cycle (1, 2).
Additionally, several pathological conditions lead to, or are a result, of glucocorticoid resistance or hypersensitivity (3) . The molecular basis of glucocorticoid resistance varies widely and is not completely understood. Generalized inherited glucocorticoid resistance (GIGR) is classified by a failure of synthetic glucocorticoids to elicit a normal physiological response. Although abnormalities in glucocorticoid responsiveness can be attributed in many cases to specific inherited mutations, epigenetic factors are also involved, since in many diseases long term glucocorticoid treatment can result in glucocorticoid resistance (4) . Several reviews on glucocorticoid resistance discuss the complexity of the syndrome and investigations of its origins (5-7)
Natural glucocorticoids and their synthetic derivatives work through the glucocorticoid receptor (GR). The GR is a member of the nuclear hormone receptor superfamily of ligand activated transcription factors. Like all members of this superfamily, the dimeric GR mediates transactivation of target genes by binding sequence-specific recognition elements (glucocorticoid response elements, GREs) in their promoter region. The homologous structural organization of the nuclear receptors is well (16) .
The GR -Multiple Promoters
The genomic organization of the human GR is shown in figure 1 . promoter multiplicity appears to be species-specific. In the mouse GR there are three unique untranslated exons, designated exon 1A, 1B, and 1C (20) . Recently, human GR mRNA was found to contain five different 5' untranslated exon 1 sequences (17) . The promoter usage and physical description of these alternative transcripts are shown in figure 1A . Although the regulation and downstream function of this promoter heterogeneity is unclear, it is suggested that these differences give rise to cell-type specific regulation of GR expression (21). By having more than one promoter sequence, it is thought GR protein expression can be differentially regulated under diverse signaling environments.
The GR -Multiple Messenger RNAs
Alternative splicing also gives rise to numerous GR isoforms. When cloned in 1985, two GR gene splicing products were identified and termed hGRα and hGRβ.
Since then several other splicing variants have been described. Immediately, hGRα was recognized as the "classical" glucocorticoid receptor composed of a single polypeptide chain of 777 amino acids, located in the cells' cytoplasm without hormone and is the primary mediator of glucocorticoid action (16) . A schematic representation of the primary GR gene and the alternative splicing event which produces hGRα and other variants is shown in figure 1B. As described earlier, the sequence, structural organization, and mechanism of action of hGRα is highly homologous with other steroid receptor superfamily members and most of our understanding of GR physiology comes from the study of this receptor isoform.
Also shown in Figure 1B is hGRβ which is generated through alternative splicing A third GR mRNA splice variant, termed GR-P, was found in tumor cells from a glucocorticoid resistant myeloma patient (39). The GR-P isoform is 676 amino acids and is encoded by exons 2-7 and part of intron 7. This truncated GR is missing a large portion of the LBD and, like hGRβ, encodes a unique carboxy terminal tail because of the inclusion of the intron fragment in the mRNA. In contrast to hGRβ, GR-P has been found to upregulate GRα mediated gene expression in some but not all cell lines.
Interestingly, the levels of this isoform can represent from 10-50% of the total GR in certain myeloma and other GR resistant hematological malignancies. Its role in these cells however has not been clearly established (40). A similar GR splicing variant was also found in corticotroph adenomas (41) 
The GR -Translational Isoforms
Various GR isoforms are also produced by alternative translation initiation.
Receptors derived from in vivo sources such as rat liver and various cell lines, as well as GR produced in vitro, fractionate into several bands upon electrophoresis. The major protein product, with an apparent molecular mass of 94 kDa, represents translation from the first initiator AUG codon, termed GR-A. However, this start codon lies within a weak Kozak translation initiation consensus sequence, which appears to result in leaky ribosomal scanning and translation initiation from downstream AUG codon(s) (42) . The next downstream start codon (met 27 in human, or met 28 in rodents) results in production of a 91 kDa GR species, termed GR-B ( Figure 1C ). Recent characterization of these two GR isoforms shows significant biochemical differences in gene transactivation potential. The shorter GR-B species is nearly twice as efficient in GRE mediated transactivation as the longer GR-A. This alternative AUG usage was first postulated following cloning of the GR gene (43) , and is consistent with observed GR proteins from multiple sources (44) . The biological significance and potential regulation of alternative initiation remains unclear, although similar observations have been made for other nuclear receptors (79) . However, the distinct biochemical activities for these isoforms suggests they may play a role in the diversity of glucocorticoid response.
The GR -Post Translationally Modified Isoforms
Many nuclear receptors, including the GR, are phosphoproteins (45) and phosphorylation of steroid receptors has been implicated as a potential mechanism for ligand-independent activity via cross-talk with other signal transduction pathways.
However, the GR appears to be refractory to any such activation in the absence of ligand (46) . Nevertheless, the GR is thought to be a substrate for several kinases and phosphatases and has been shown to be poly-phosphorylated on serine and threonine residues, in the amino terminal portion of the protein ( Figure 1D ) (47) . Although the precise role of each specific phosphorylation event remains unclear, mutation of multiple phosphorylation sites has a profound impact on the receptor stability, protein half-life and signaling in a promoter-specific context (48) . Both constitutive, or basal phosphorylation, as well as ligand-induced phosphorylation of the GR occur. In addition, there appears to be a strong cell-cycle dependency of GR phosphorylation (49), as well as a potential role of phosphorylation in nuclear-cytoplasmic shuttling (50).
A recent study has shown that the mouse GR is a substrate for post-translational ubiquitination, targeting the receptor for proteosomal degradation. In this case, a lysine residue found in a PEST degradation motif in the amino terminal domain, was mutated to alanine. This mutation blocks ligand-dependent GR down regulation and markedly enhances GR signaling (51) . Another related post-translational modification of the GR is sumoylation. The GR has recently been shown to be sumoylated in vitro and this modification may modulate transcriptional regulation (52).
The GR -Polymorphisms and Mutants
The study of polymorphisms of the GR gene presents a clear example of how small changes in receptor expression levels, functional and/or protein interactions can result in diverse clinical manifestations. Mutant forms of the GR were characterized long before the receptor itself was cloned (53) . Table 1 
The GR -Species Differences
The full length GR has been cloned and sequenced from over a dozen unique species including human, several non-human primates, rat, mouse, guinea pig, African frog, rainbow trout, flounder and others (see the Glucocorticoid Receptor Resource:
http://nrr.georgetown.edu/GRR/GRR.html and references therein). In addition, partial sequences exist for several species including chicken, sheep, and pig. The homology among mammalian species is relatively high, with non-mammalian species exhibiting significant heterogeneity in both sequence and length (59, 60). Just as among classes of nuclear receptor superfamily members, greater sequence homology between species lies within the GR DNA and ligand binding domains. However, rather profound differences in glucocorticoid sensitivity are observed among species. For example, the guinea pig is a well known example of a cortico-resistant species (61) as are several New
World primates, such as the squirrel monkey and the marmoset (62). However, molecular analysis of these receptors suggests the underlying mechanism of glucocorticoid resistance in these species are distinct. For example, within the amino terminal portion of the guinea pig GR LBD are a cluster of non conserved changes from human and other species which appear to cause glucocorticoid resistance in that species (63) . In contrast, New World primates' GR LBD is highly homologous to that of both human and Old World primates. Glucocorticoid resistance in New World primates has been linked to a cytosolic factor reducing the sensitivity to circulating glucocorticoids in these species (64) .
The GR -Nongenome-active Isoforms
A notable paradox of glucocorticoid biology is the rapid release of the hormone during a stress response (seconds) and the perceived delay (hours) in eliciting a genomic response consistent with the classical action of steroid and other nuclear hormone receptors. In the past several years there has been an increased interest in non-genomic and/or membrane-associated actions of steroids and their receptors. This is the subject of several reviews (65) (66) (67) . Distinct GR forms could presumably mediate the rapid actions of glucocorticoids. One possibility is the presence of a membrane bound or associated form of the GR (22, 68). This receptor may either be a unique gene product, as proposed for the PR (69), or a modified version of the classical GR capable of integrating into the plasma membrane. Another possibility is that a cytosolic subset of GR mediates the rapid actions of glucocorticoids by participating in signal transduction pathways usually associated with membrane receptor signaling events (70) . Whether this receptor turns out to be a unique gene product, specific isoform, or merely a subset of the classical receptor which alters cellular phenotype through protein-protein interactions with factors such as NF-κB etc., remains to be determined.
Conclusion
Today in the pharmaceutical industry, small molecule ligands are being developed to interact with nuclear receptors with greater specificity and to promote particular biological functions of the glucocorticoid receptor without eliciting side effects. We propose that nature has chosen an alternative pathway toward specificity and diversity in glucocorticoid receptor signaling. The complexity of glucocorticoid biology lies more in the variety of receptors themselves rather than in the ligands to which they bind.
Assuming that there are four or perhaps more GR isoforms in a cell, combined with up to eight phosphorylation sites, at least one ubiquitination site, and perhaps several sumoylation sites, the capacity to generate dozens of unique GRs in a single cell presents an enormous potential for signaling diversity. In that way cells could produce unique 15 biological response to the same hormone. The value of this hypothesis will come if specific isoforms can be linked to the control of a specific gene or sets of genes. 
